OTCM
AQPW
Market cap1mUSD
Apr 24, Last price
0.00USD
Name
Golden Ally Lifetech Group Inc
Chart & Performance
Profile
Golden Ally Lifetech Group, Inc., a development stage company, focuses on developing advanced technologies, energy solutions, and medical devices. It focuses on development of bioscience and sport medicines, including Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems. The company also offers InCharge magnetic-based battery device that provides energy; and develops applications for de-icing application of graphene for use in the airline industry. The company was formerly known as Signet International Holdings, Inc. and changed its name to Golden Ally Lifetech Group, Inc. in July 2022. Golden Ally Lifetech Group, Inc. was incorporated in 2003 and is based in Austin, Texas.
IPO date
Mar 09, 2007
Employees
10
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
---|---|---|---|---|
2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
Income | ||||
Revenues | ||||
Cost of revenue | 6,112 | |||
Unusual Expense (Income) | ||||
NOPBT | (6,112) | |||
NOPBT Margin | ||||
Operating Taxes | 3 | |||
Tax Rate | ||||
NOPAT | (6,112) | |||
Net income | (6,072) 3,371.24% | |||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | ||||
BB yield | ||||
Debt | ||||
Debt current | 70 | |||
Long-term debt | 132 | |||
Deferred revenue | ||||
Other long-term liabilities | ||||
Net debt | (381) | |||
Cash flow | ||||
Cash from operating activities | (6,086) | |||
CAPEX | ||||
Cash from investing activities | (1,000) | |||
Cash from financing activities | 4,669 | |||
FCF | (7,241) | |||
Balance | ||||
Cash | 582 | |||
Long term investments | ||||
Excess cash | 582 | |||
Stockholders' equity | (6,045) | |||
Invested Capital | 7,737 | |||
ROIC | ||||
ROCE | ||||
EV | ||||
Common stock shares outstanding | 8,490,582 | |||
Price | ||||
Market cap | ||||
EV | ||||
EBITDA | (6,072) | |||
EV/EBITDA | ||||
Interest | ||||
Interest/NOPBT |